Pediatric differentiated thyroid carcinoma: An update from the APSA Cancer Committee
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Jun 2020 · 1 min read
In brief
In brief
This APSA Cancer Committee review examines current surgical management of differentiated thyroid carcinoma in children and adolescents, covering diagnostic approaches, risk stratification, and treatment strategies. Total thyroidectomy with compartment-based lymph node resection remains the primary treatment, with emerging roles for molecular genetics and targeted therapies in refractory disease.
Written by the GCMD Library team from the article.
Abstract
Background
Differentiated thyroid carcinomas (DTCs) are rare in young children but represent almost 10% of all malignancies diagnosed in older adolescents.
Methods
This article reviews the recent literature describing surgical therapeutic approaches to pediatric DTC, associated complications, and long-term recurrence and survival outcomes.
Results
Similar to adult thyroid cancers, pediatric DTCs are more common in females and are associated with thyroid nodules, family history of thyroid cancer, radiation exposure, iodine deficiency, autoimmune thyroid disease, and genetic syndromes. Management of thyroid cancers in children involves ultrasound imaging, fine needle aspiration, and surgical resection with treatment decisions based on clinical and radiological features, cytology and risk assessment.
Conclusions
Total thyroidectomy and compartment based resection of clinically involved lymph node basins form the cornerstone of treatment of DTC. There is an evolving literature regarding the use of molecular genetics to inform treatment strategies and the use of targeted therapies to treat iodine refractory and surgically unresectable progressive disease.
Type of study
Summary review.
Level of evidence
This is a review article of previously published Level 1–5 articles that includes expert opinion (Level 5).